These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21163238)

  • 21. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues.
    Dietrich J; Norden AD; Wen PY
    Curr Opin Neurol; 2008 Dec; 21(6):736-44. PubMed ID: 19060566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of recurrent high-grade gliomas.
    Wen PY; Brandes AA
    Curr Opin Neurol; 2009 Dec; 22(6):657-64. PubMed ID: 19770658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of bevacizumab for radiation-induced cerebral necrosis in children.
    Preuss M; Hirsch W; Hoffmann KT; Bernhard MK; Siekmeyer M; Kiess W; Meixensberger J; Wurm RE; Merkenschlager A
    Pediatr Neurosurg; 2013; 49(2):81-5. PubMed ID: 24435068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimotuzumab treatment of malignant gliomas.
    Bode U; Massimino M; Bach F; Zimmermann M; Khuhlaeva E; Westphal M; Fleischhack G
    Expert Opin Biol Ther; 2012 Dec; 12(12):1649-59. PubMed ID: 23043252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.
    Chamberlain MC
    Neurology; 2006 Dec; 67(11):2089; author reply 2089. PubMed ID: 17159134
    [No Abstract]   [Full Text] [Related]  

  • 26. Am I obligated to give therapy against my better judgment?
    Helft PR
    Oncology (Williston Park); 2012 Oct; 26(10):995-6. PubMed ID: 23176017
    [No Abstract]   [Full Text] [Related]  

  • 27. The paradoxical effect of bevacizumab in the therapy of malignant gliomas.
    Chamberlain MC
    Neurology; 2011 Aug; 77(8):803; author reply 803-4. PubMed ID: 21860011
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental approaches for the treatment of malignant gliomas.
    Arko L; Katsyv I; Park GE; Luan WP; Park JK
    Pharmacol Ther; 2010 Oct; 128(1):1-36. PubMed ID: 20546782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.
    DeSalvo MN
    J Radiol Case Rep; 2012 Jul; 6(7):9-16. PubMed ID: 23365707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation-induced myelopathy: treatment with bevacizumab.
    Chamberlain MC; Eaton KD; Fink J
    Arch Neurol; 2011 Dec; 68(12):1608-9. PubMed ID: 22159063
    [No Abstract]   [Full Text] [Related]  

  • 31. [III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].
    Kurozumi K; Onishi M; Ichikawa T; Fujii K; Ishida J; Shimazu Y; Date I
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):718-22. PubMed ID: 23957062
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bevacizumab Treatment for Malignant Glioma Based on Basic Research and Clinical Trial].
    Takano S
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):694-701. PubMed ID: 27459747
    [No Abstract]   [Full Text] [Related]  

  • 33. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
    Dasgupta P; Ou A; Lin H; Gregory T; Alfaro-Munoz KD; Yuan Y; Afshar-Khargan V; Kamiya-Matsuoka C; Rousseau JF; Majd NK
    J Neurooncol; 2024 Mar; 167(1):181-188. PubMed ID: 38372903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly diagnosed high-grade gliomas.
    Giglio P; Villano JL
    Curr Treat Options Neurol; 2010 Jul; 12(4):309-20. PubMed ID: 20842590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab.
    Voss M; Batarfi A; Steidl E; Wagner M; Forster MT; Steinbach JP; Rödel CM; Bojunga J; Ronellenfitsch MW
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic therapy in high-grade glioma (treatment and toxicity).
    Taylor J; Gerstner ER
    Curr Treat Options Neurol; 2013 Jun; 15(3):328-37. PubMed ID: 23417315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report.
    Zhuang H; Yuan X; Sun D; Bian J; Chang JY; Yuan Z; Wang P
    Oncotarget; 2016 Mar; 7(11):13265-13268. PubMed ID: 26933810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases.
    Mangesius J; Mangesius S; Demetz M; Uprimny C; Di Santo G; Galijasevic M; Minasch D; Gizewski ER; Ganswindt U; Virgolini I; Thomé C; Freyschlag CF; Kerschbaumer J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review.
    Liao G; Khan M; Zhao Z; Arooj S; Yan M; Li X
    Front Oncol; 2021; 11():593449. PubMed ID: 33842309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.